[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
January 17, 1966

Increase of Serum β-Glucuronidase Activity in Human Diabetes Mellitus

Author Affiliations

From the Harrison Department of Surgical Research and the Hospital of the University of Pennsylvania, School of Medicine, University of Pennsylvania, Philadelphia.; Reprint requests to 3400 Spruce St, Philadelphia 19104 (Dr. Miller).

JAMA. 1966;195(3):189-192. doi:10.1001/jama.1966.03100030083020

Serum β-glucuronidase activity has been determined by the new, specific method of Fishman in 100 patients with diabetes mellitus. The enzyme activity was increased significantly as compared with suitable controls—a mean value of 2,160 units for the diabetics vs 1,260 for the controls. It was not related to the intensity of hyperglycemia or the requirement for insulin. It is believed that the increased activity of β-glucuronidase can be explained by the operation of a noninsulin-sensitive pathway for glucose metabolism such as the glucuronic acid cycle. This pathway is known to become more active in diabetes. It is speculated that acceleration of the glucuronic acid cycle stimulates the synthesis of mucopolysaccharides and glycoproteins, and this induces greater β-glucuronidase activity to reduce their concentration.